NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE

Pre-Launch

naltrexone hydrochloride; bupropion hydrochloride

ANDAORALTABLET, EXTENDED RELEASE

Lifecycle

Pre-Launch

Data completeness

2/8 — Basic

NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE (naltrexone hydrochloride; bupropion hydrochloride) by Teva is components: naltrexone, an opioid antagonist, and bupropion, a relatively weak inhibitor of the neuronal reuptake of dopamine and norepinephrine. Approved for combination with a reduced-calorie diet, increased physical activity to reduce excess body weight, maintain weight reduction long term in adults with obesity and 1 more indications.

Drug data last refreshed 1mo ago

Mechanism of Action

components: naltrexone, an opioid antagonist, and bupropion, a relatively weak inhibitor of the neuronal reuptake of dopamine and norepinephrine. Nonclinical studies suggest that naltrexone and bupropion have effects on two separate areas of the brain involved in the regulation of food intake: the…

Indications (4)

combination with a reduced-calorie diet increased physical activity to reduce excess body weight

Worked on NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.